Leerink Partners Maintains Outperform on Twist Bioscience, Raises Price Target to $190
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $160 to $190.
Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $160 to $190.